American Heart Journal
Volume 157, Issue 2 , Pages 335-344 , February 2009

Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations

  • Thomas J. Povsic, MD, PhD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Thomas J. Povsic MD, PhD, Department of Cardiology, Box 3126, Duke University Medical Center, Durham, NC 27710.
    • ,
  • Katherine L. Zavodni, BA

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Enrikas Vainorius, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Jennifer F. Kherani, BS

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Pascal J. Goldschmidt-Clermont, MD

      Affiliations

    • Miller School of Medicine, University Of Miami, Miami, FL
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

Received 2 February 2008 ,Accepted 14 October 2008.

References 

  1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  2. Hill JM, Zalos G, Halcox JPJ, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Eng J Med. 2003;348:593–600
  3. Kunz G, Liang G, Cuculi G, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J. 2006;152:190–195
  4. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:e1–e7
  5. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981–2987
  6. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007
  7. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–1457
  8. Schatteman G. Are circulating CD133+ cells biomarkers of vascular disease. Arterioscler Thromb Vasc Biol. 2005;25:270–271
  9. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating CD34+ cells identifies a population of functional endothelial precursors. Hemost Thromb Vasc Biol. 2000;95:952–958
  10. Povsic T, Zavodni K, Kelly F, et al. Circulating endogenous progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol. 2007;53:2243–2248
  11. Gentry T, Foster S, Winstead L, et al. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy. 2007;9:259–274
  12. Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. PNAS. 2006;103:11707–11712
  13. George J, Shmilovich H, Deutsch V, et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 2006;12:331–335
  14. Heiss C, Keymel S, Niesler U, et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441–1448
  15. Powell TM, Paul JD, Hill JM, et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:296–301
  16. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885–2890
  17. Herbrig K, Pistrosch F, Oelschlaegel U, et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis. 2004;44:840–849
  18. Rehman J, Li J, Orschell CM, et al. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation. 2003;107:1164–1169
  19. Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314–322
  20. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288–293
  21. Gulati R, Jevremovic D, Peterson TE, et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res. 2003;93:1023–1025
  22. Guven H, Shepherd RM, Bach RG, et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol. 2006;48:1579–1587
  23. Eizawa T, Ikeda U, Murakami Y, et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart. 2004;90:685–686
  24. Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–3112
  25. Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337–346
  26. Case J, Mead LE, Bessler WK, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–1118
  27. Nagano M, Yamashita T, Hamada H, et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood. 2007;110:151–160
  28. Redondo S, Hristov M, Gordillo-Moscoso AA, et al. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3− lymphocyte sub-population. J Immunol Methods. 2008;335:21–27
  29. Friedrich EB, Walenta K, Scharlau J, et al. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 2006;98:e20–e25
  30. Quirci N, Soligo D, Caneva L, et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol. 2001;115:186–194
  31. Nowak G, Karrar A, Holmen C, et al. Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation. 2004;110:3699–3707

 This study was funded in part by National Heart, Lung, and Blood Institute (NHLBI) (Bethesda, MD) K-18 HL081419-01A1 to T.J.P, a Society of Geriatric Cardiology Merck Geriatric Cardiology Research Award to T.J.P., and grants from the Duke Clinical Research Institute and Medtronic Inc (Minneapolis, MN), through the Medtronic-Duke Strategic Alliance to T.J.P.

 Dr. J. Michael DiMaio served as guest editor for this manuscript.

PII: S0002-8703(08)00900-9

doi: 10.1016/j.ahj.2008.10.010

American Heart Journal
Volume 157, Issue 2 , Pages 335-344 , February 2009

Article Tools

* Image Usage & Resolution